Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003771priorityCriticalpatent/ECSP003771A/en
Publication of ECSP003771ApublicationCriticalpatent/ECSP003771A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Un método para prevenir la diarrea causada por la administración de irinotecan o una sal o un metabolito farmacéuticamente aceptable del mismo, que comprende administrar a un paciente sometido al tratamiento con una terapia que contiene irinotecan una cantidad efectiva de un octreótido o una sal farmacéuticamente aceptable del mismoA method for preventing diarrhea caused by the administration of irinotecan or a pharmaceutically acceptable salt or metabolite thereof, which comprises administering to a patient undergoing treatment with an irinotecan-containing therapy an effective amount of an octreotide or a pharmaceutically acceptable salt of the same
ECSP0037712000-11-172000-11-17
METHOD TO PREVENT DIARRHEA
ECSP003771A
(en)
Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates.
USE OF (+) -ALFA- (2,3-DIMETOXIFENIL) -1- [2- (4-FLUOROPHENYL) ETHYL] -4-PIPERIDINMETHANOL OR ITS DRUG FOR THE MANUFACTURE OF A MEDICINAL PRODUCT IN THE TREATMENT OF SYMPTOMS OF DEMENTIA AND OF PSYCHOSIS INDUCED BY DOPAMINE